Skip to main content
. 2022 Apr 8;32(5):e2347. doi: 10.1002/rmv.2347

FIGURE 5.

FIGURE 5

Assignment of epitope residues of (a) Receptor binding domain (RBD), (b) N‐terminal domain (NTD), (c) SD2, and (d) SH‐targeted by neutralising monoclonal antibodies (MAbs) illustrated in Figure 4. NTD: N‐terminal domain; RBD: Receptor binding domain; RBM: Receptor‐binding motif, SD2: Subdomain two; SH: Stem helix